DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Hilgartner MW, Knatterud GL.
The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitors.
Blood 1983;
61 (01) 36-40
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.